Coronavirus: India’s Bharat Biotech goals to make 700 mln doses of vaccine in 2021
India’s Bharat Biotech is aiming to have a manufacturing capability of about 700 million doses of its COVID-19 vaccine ...
India’s Bharat Biotech is aiming to have a manufacturing capability of about 700 million doses of its COVID-19 vaccine ...
India oi-Deepika S | Updated: Monday, January 4, 2021, 23:57 New Delhi, Jan 04: Bharat Biotech, which has ...
Image Source : PTI Bharat Biotech gets licensing permission to manufacture Covaxin The Central Licensing Authority on Sunday granted ...
India oi-Deepika S | Published: Sunday, January 3, 2021, 19:29 New Delhi, Jan 03: Dr Randeep Guleria, the ...
India has formally approved the emergency use of two coronavirus vaccines as it prepares for one of the world's ...
India on Sunday formally authorised the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University, and ...
Express News Service NEW DELHI: V G Somani, Drug Controller General of India (DCGI) on Sunday announced that the recommendations ...
Covaxin has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials Hyderabad: Bharat Biotech ...
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council of ...
India oi-Briti Roy Barman | Published: Friday, January 1, 2021, 10:19 New Delhi, Dec 01: An expert panel ...
Copyright 2022 © BM Global News. Enjoy our Latest World News.